Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 21, 2025Open Access

Theranostic Nanoplatforms in Nuclear Medicine: Current Advances, Emerging Trends, and Perspectives for Personalized Oncology

View Full Paper
Ask AI
Bookmark
Share

Authors

MSMaría Jimena SalgueiroMZMarcela Zubillaga

Discussion

Loading...

Member takes

Overview

This review highlights advancements in theranostic nanoplatforms for imaging and therapy in oncology, suggesting opportunities for improved patient outcomes.

Key Points

  • Theranostic nanoplatforms integrate imaging and treatment, enhancing personalized approaches in oncology.
  • Current advancements focus on multifunctional nanocarriers that combine diagnostic radionuclides with various therapeutic agents.
  • Challenges in pharmacokinetics, toxicity, and regulatory processes are crucial for successful clinical application.
  • Future perspectives indicate theranostic nanoplatforms may significantly alter the landscape of targeted diagnostics and radiotherapy.

Cite This Study

Salgueiro et al. (2025) studied this question.

synapsesocial.com/papers/689a02c9e6551bb0af8cd088https://doi.org/10.20944/preprints202507.1404.v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Nanoradiopharmaceuticals: Design Principles, Radiolabeling Strategies, and Biomedicine Applications.2025
  2. 2Conjugate Nanoparticles in Cancer Theranostics2025 · 10 citations
  3. 3Multifunctional Nanoplatforms Bridging Diagnostics and Therapeutics in Cancer2025
  4. 4Multifunctional Nanoplatforms Bridging Diagnostics and Therapeutics in Cancer2025
  5. 5Recent Advancement of Nanotheranostics in Cancer Applications2024 · 5 citations